TY  - RPRT
TI  - Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity
AU  - Zhu, Y.
AU  - Yu, D.
AU  - Yan, H.
AU  - Chong, H.
AU  - He, Y.
PY  - 2020
DO  - 10.1101/2020.03.26.009233
UR  - https://www.biorxiv.org/content/10.1101/2020.03.26.009233v1
ID  - 10.1101/2020.03.26.009233
ER  -